✦ LIBER ✦

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

✍ Scribed by Goldberg, R. M.

Book ID: 125546571
Publisher: American Society of Clinical Oncology
Year: 2004
Tongue: English
Weight: 296 KB
Volume: 22
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2004.09.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Addition of Aflibercept to Fluorouracil,

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

✍ Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausova, J.; Macarulla, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 532 KB

6578 A randomized phase II study of irin

6578 A randomized phase II study of irinotecan monotherapy versus irinotecan plus 5-fluorouracil/leucovorin combination as a salvage chemotherapy in previously treated patients with advanced/metastatic gastric cancer

✍ Park, Y.; Sym, S.; Park, J.; Cho, E.; Shin, D.; Lee, J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Multicenter Phase II Study of Fixed Sequ

Multicenter Phase II Study of Fixed Sequences of Capecitabine Combined with Oxaliplatin or Irinotecan in Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Javier Cassinello; Jose Valero Álvarez; María José García López; Eduardo Pujol; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 488 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB

A systematic review of salvage therapy t

A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/− targeted therapy

✍ Nielsen, Dorte Lisbet; Palshof, Jesper Andreas; Larsen, Finn Ole; Jensen, Benny 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 535 KB